Abbott gets US FDA approval for paediatric HIV drug Kaletra
Friday, November 16, 2007 17:00 IST Abbott Park, Illinois
Abbott announced that it has received US Food and Drug Administration (FDA) approval for a new lower-strength tablet formulation of its leading HIV protease inhibitor, Kaletra (lopinavir/ritonavir)